Department
Molecular and Cellular Biology
Document Type
Article
Publication Date
4-1-2015
Abstract
Background
Gluten sensitivity and the incidence of Celiac disease are ever increasing. The aim was to measure the effectiveness of an enzyme based dietary supplement on the reduction of symptoms encountered upon the consumption of gluten.
Results
The data showed a statistically significant improvement when compared to the placebo group in the following categories: pain, bloating, emptying of bowels, hunger pains, rumbling of stomach, lower energy levels, headaches, and food cravings. There was no statistically signficant improvement in the following symptoms: comfort, nausea, and loss of appetite.
Conclusion
Overall, the dietary supplement, Glutalytic, reduced many of the symptoms that are encountered upon the consumption of gluten.